Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting

Retrospective Observation of Low-Dose Rituximab Treatment in Chinese Patients With Neuromyelitis Optica Spectrum Disorders in a Real-World Setting

Objective: This study aimed to investigate the efficacy and safety of low-dose rituximab (RTX) in the treatment of neuromyelitis optica spectrum disorders (NMOSD) patients.Methods: NMOSD patients were treated with RTX at ~25% of the standard dose. The annualized relapse rate (ARR), expanded disabili...

Full description

Bibliographic Details
Main Authors: Haibing Xiao, Wenshuang Zeng, Ling Li, Lina Li, Yuzhen Cui, Jie Wang, Jinhao Ye, Qingyan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Neurology
Subjects:
neuromyelitis optica spectrum disorders
rituximab
aquaporin 4 antibody
annualized relapse rate
multiple sclerosis
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00642/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2020.00642/full

Similar Items